INHALED IMATINIB FOR PULMONARY ARTERIAL HYPERTENSION CLINICAL TRIAL: DESIGN OF THE IMPACT PHASE 2B/3 STUDY DESIGN

被引：1
|
作者：
Gillies, Hunter
Chakinala, Murali M.
Dake, Ben
Feldman, Jeremy P.
Hoeper, Marius M.
Humbert, Marc
Jing, Zhi-Cheng
Langley, Jonathan
McLaughlin, Vallerie
Niven, Ralph
Rosenkranz, Stephan H.
Zhang, Xiaosha
Hill, Nicholas S.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1923
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2325A / 2329A
页数：5
相关论文
共 50 条
  • [1] IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension
    Gillies, Hunter
    Chakinala, Murali M.
    Dake, Benjamin T.
    Feldman, Jeremy P.
    Hoeper, Marius M.
    Humbert, Marc
    Jing, Zhi-Cheng
    Langley, Jonathan
    McLaughlin, Vallerie V.
    Niven, Ralph W.
    Rosenkranz, Stephan
    Zhang, Xiaosha
    Hill, Nicholas S.
    PULMONARY CIRCULATION, 2024, 14 (01)
  • [2] Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
    Nikkho, Sylvia
    Fernandes, Peter
    White, R. James
    Deng, Chunqin
    Farber, Harrison W.
    Corris, Paul A.
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [3] Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
    Howard, Luke S. G. E.
    Watson, Geoffrey M. J.
    Wharton, John
    Rhodes, Christopher J.
    Chan, Kakit
    Khengar, Rajeshree
    Robbins, Peter A.
    Kiely, David G.
    Condliffe, Robin
    Elliott, Charlie A.
    Pepke-Zaba, Joanna
    Sheares, Karen
    Morrell, Nicholas W.
    Davies, Rachel
    Ashby, Deborah
    Gibbs, J. Simon R.
    Wilkins, Martin R.
    PULMONARY CIRCULATION, 2013, 3 (01) : 100 - 107
  • [4] Clinical trial design and new therapies for pulmonary arterial hypertension
    Sitbon, Olivier
    Gomberg-Maitland, Mardi
    Granton, John
    Lewis, Michael I.
    Mathai, Stephen C.
    Rainisio, Maurizio
    Stockbridge, Norman L.
    Wilkins, Martin R.
    Zamanian, Roham T.
    Rubin, Lewis J.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [5] End Points and Clinical Trial Design in Pulmonary Arterial Hypertension
    McLaughlin, Vallerie V.
    Badesch, David B.
    Delcroix, Marion
    Fleming, Thomas R.
    Gaine, Sean P.
    Galie, Nazzareno
    Gibbs, J. Simon R.
    Kim, Nick H.
    Oudiz, Ronald J.
    Peacock, Andrew
    Provencher, Steeve
    Sitbon, Olivier
    Tapson, Victor F.
    Seeger, Werner
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) : S97 - S107
  • [6] Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
    Caccamo, Marco
    Harrell, Frank E. E.
    Hemnes, Anna R. R.
    PULMONARY CIRCULATION, 2023, 13 (03)
  • [7] SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension
    Waxman, Aaron B.
    Systrom, David M.
    Manimaran, Solaiappan
    Pena, Janethe de Oliveira
    Lu, Jonathan
    Rischard, Franz P.
    CIRCULATION-HEART FAILURE, 2024, 17 (05) : E011227
  • [8] AN INNOVATIVE PHASE 2 CLINICAL TRIAL DESIGN FOR ASSESSMENT OF CS1: A NOVEL THERAPY IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Benza, Raymond L.
    Bergh, Niklas N. B.
    Adamson, Philip B.
    Dahlof, Bjorn
    CHEST, 2022, 162 (04) : 2335A - 2336A
  • [9] Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension
    Lajoie, Annie Christine
    Bonnet, Sebastien
    Provencher, Steeve
    LANCET RESPIRATORY MEDICINE, 2017, 5 (07): : 544 - 546
  • [10] Advancing clinical trial design in pulmonary hypertension
    Grieve, Andy P.
    Chow, Shien-Chung
    Curram, John
    Dawe, Stephen
    Harnisch, Lutz O.
    Henig, Noreen R.
    Hung, Hsien Ming J.
    Ivy, D. Dunbar
    Kawut, Steven M.
    Rahbar, Mohammad H.
    Xiao, Shen
    Wilkins, Martin R.
    PULMONARY CIRCULATION, 2013, 3 (01) : 217 - 225
12345